NUPERCAINAL- dibucaine ointment
Dr. Reddy's Laboratories Inc.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Active ingredient
Dibucaine 1%
Purpose
Hemorrhoidal ointment
Use
- temporarily relieves pain and itching due to hemorrhoids or other anorectal disorders
Warnings
For external use only
Allergy alert
- certain persons can develop allergic reactions to ingredients in this product. If the symptom being treated does not subside or if redness, irritation, swelling, bleeding or other symptoms develop or increase, discontinue use and ask a doctor.
Do not use
- in or near the eyes
- in children under 2 years of age
When using this product
- do not use more than directed unless directed by a doctor
- do not put this product into the rectum by using fingers or any mechanical device or applicator
Stop use and ask a doctor if
- bleeding occurs
- condition worsens or does not improve within 7 days
If pregnant or breast-feeding, ask a health care professional before use.
Keep out of reach of children. If swallowed, get medical help or contact a poison control center right away.
Directions
- adults and children 12 years and over: if possible, clean the affected area with mild soap and warm water and rinse thoroughly. gently dry by patting or blotting with toilet tissue or a soft cloth before applying.
- apply externally to the affected area up to 3 or 4 times daily
- children under 12 years of age: ask a doctor
Other information
- store at 20-25°C (68-77°F)
Inactive ingredients
acetone sodium bisulfite, lanolin, light mineral oil, purified water, white petrolatum
Questions?
call 1-800-790-6417
PRINCIPAL DISPLAY PANEL - 56.7g Tube Box
LONGEST LASTING
INGREDIENT
UP TO 8 HOURS
NDC 55741-402-02
NUPERCAINAL®
HEMORRHOIDAL OINTMENT
DIBUCAINE 1%
Fast Temporary Relief of Pain, Itching,
and Burning Due to Hemorrhoids.
NET WT 2 oz. (56.7g)
Dr. Reddy's Laboratories Inc.
